Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood–brain barrier into brain

Delivering highly water soluble drugs across blood–brain barrier (BBB) is a crucial challenge for the formulation scientists. A successful therapeutic intervention by developing a suitable drug delivery system may revolutionize treatment across BBB. Efforts were given here to unravel the capability...

Full description

Bibliographic Details
Main Authors: Lopamudra Dutta, Biswajit Mukherjee, Tapash Chakraborty, Malay Kumar Das, Laboni Mondal, Sanchari Bhattacharya, Raghuvir H. Gaonkar, Mita Chatterjee Debnath
Format: Article
Language:English
Published: Taylor & Francis Group 2018-01-01
Series:Drug Delivery
Subjects:
Online Access:http://dx.doi.org/10.1080/10717544.2018.1435749
_version_ 1819013287799422976
author Lopamudra Dutta
Biswajit Mukherjee
Tapash Chakraborty
Malay Kumar Das
Laboni Mondal
Sanchari Bhattacharya
Raghuvir H. Gaonkar
Mita Chatterjee Debnath
author_facet Lopamudra Dutta
Biswajit Mukherjee
Tapash Chakraborty
Malay Kumar Das
Laboni Mondal
Sanchari Bhattacharya
Raghuvir H. Gaonkar
Mita Chatterjee Debnath
author_sort Lopamudra Dutta
collection DOAJ
description Delivering highly water soluble drugs across blood–brain barrier (BBB) is a crucial challenge for the formulation scientists. A successful therapeutic intervention by developing a suitable drug delivery system may revolutionize treatment across BBB. Efforts were given here to unravel the capability of a newly developed fatty acid combination (stearic acid:oleic acid:palmitic acid = 8.08:4.13:1) (ML) as fundamental component of nanocarrier to deliver highly water soluble zidovudine (AZT) as a model drug into brain across BBB. A comparison was made with an experimentally developed standard phospholipid-based nanocarrier containing AZT. Both the formulations had nanosize spherical unilamellar vesicular structure with highly negative zeta potential along with sustained drug release profiles. Gamma scintigraphic images showed both the radiolabeled formulations successfully crossed BBB, but longer retention in brain was observed for ML-based formulation (MGF) as compared to soya lecithin (SL)-based drug carrier (SYF). Plasma and brain pharmacokinetic data showed less clearance, prolonged residence time, more bioavailability and sustained release of AZT from MGF in rats compared to those data of the rats treated with SYF/AZT suspension. Thus, ML may be utilized to successfully develop drug nanocarrier to deliver drug into brain across BBB, in a sustained manner for a prolong period of time and may provide an effective therapeutic strategy for many diseases of brain. Further, many anti-HIV drugs cannot cross BBB sufficiently. Hence, the developed formulation may be a suitable option to carry those drugs into brain for better therapeutic management of HIV.
first_indexed 2024-12-21T01:57:33Z
format Article
id doaj.art-e1aea8c07401492c83233eac03bc0506
institution Directory Open Access Journal
issn 1071-7544
1521-0464
language English
last_indexed 2024-12-21T01:57:33Z
publishDate 2018-01-01
publisher Taylor & Francis Group
record_format Article
series Drug Delivery
spelling doaj.art-e1aea8c07401492c83233eac03bc05062022-12-21T19:19:44ZengTaylor & Francis GroupDrug Delivery1071-75441521-04642018-01-0125150451610.1080/10717544.2018.14357491435749Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood–brain barrier into brainLopamudra Dutta0Biswajit Mukherjee1Tapash Chakraborty2Malay Kumar Das3Laboni Mondal4Sanchari Bhattacharya5Raghuvir H. Gaonkar6Mita Chatterjee Debnath7Jadavpur UniversityJadavpur UniversityDibrugarh UniversityDibrugarh UniversityJadavpur UniversityJadavpur UniversityCSIR-Indian Institute of Chemical BiologyCSIR-Indian Institute of Chemical BiologyDelivering highly water soluble drugs across blood–brain barrier (BBB) is a crucial challenge for the formulation scientists. A successful therapeutic intervention by developing a suitable drug delivery system may revolutionize treatment across BBB. Efforts were given here to unravel the capability of a newly developed fatty acid combination (stearic acid:oleic acid:palmitic acid = 8.08:4.13:1) (ML) as fundamental component of nanocarrier to deliver highly water soluble zidovudine (AZT) as a model drug into brain across BBB. A comparison was made with an experimentally developed standard phospholipid-based nanocarrier containing AZT. Both the formulations had nanosize spherical unilamellar vesicular structure with highly negative zeta potential along with sustained drug release profiles. Gamma scintigraphic images showed both the radiolabeled formulations successfully crossed BBB, but longer retention in brain was observed for ML-based formulation (MGF) as compared to soya lecithin (SL)-based drug carrier (SYF). Plasma and brain pharmacokinetic data showed less clearance, prolonged residence time, more bioavailability and sustained release of AZT from MGF in rats compared to those data of the rats treated with SYF/AZT suspension. Thus, ML may be utilized to successfully develop drug nanocarrier to deliver drug into brain across BBB, in a sustained manner for a prolong period of time and may provide an effective therapeutic strategy for many diseases of brain. Further, many anti-HIV drugs cannot cross BBB sufficiently. Hence, the developed formulation may be a suitable option to carry those drugs into brain for better therapeutic management of HIV.http://dx.doi.org/10.1080/10717544.2018.1435749nanosize lipid carrierblood–brain barriergamma scintigraphypharmacokineticsbiodistribution
spellingShingle Lopamudra Dutta
Biswajit Mukherjee
Tapash Chakraborty
Malay Kumar Das
Laboni Mondal
Sanchari Bhattacharya
Raghuvir H. Gaonkar
Mita Chatterjee Debnath
Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood–brain barrier into brain
Drug Delivery
nanosize lipid carrier
blood–brain barrier
gamma scintigraphy
pharmacokinetics
biodistribution
title Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood–brain barrier into brain
title_full Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood–brain barrier into brain
title_fullStr Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood–brain barrier into brain
title_full_unstemmed Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood–brain barrier into brain
title_short Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood–brain barrier into brain
title_sort lipid based nanocarrier efficiently delivers highly water soluble drug across the blood brain barrier into brain
topic nanosize lipid carrier
blood–brain barrier
gamma scintigraphy
pharmacokinetics
biodistribution
url http://dx.doi.org/10.1080/10717544.2018.1435749
work_keys_str_mv AT lopamudradutta lipidbasednanocarrierefficientlydelivershighlywatersolubledrugacrossthebloodbrainbarrierintobrain
AT biswajitmukherjee lipidbasednanocarrierefficientlydelivershighlywatersolubledrugacrossthebloodbrainbarrierintobrain
AT tapashchakraborty lipidbasednanocarrierefficientlydelivershighlywatersolubledrugacrossthebloodbrainbarrierintobrain
AT malaykumardas lipidbasednanocarrierefficientlydelivershighlywatersolubledrugacrossthebloodbrainbarrierintobrain
AT labonimondal lipidbasednanocarrierefficientlydelivershighlywatersolubledrugacrossthebloodbrainbarrierintobrain
AT sancharibhattacharya lipidbasednanocarrierefficientlydelivershighlywatersolubledrugacrossthebloodbrainbarrierintobrain
AT raghuvirhgaonkar lipidbasednanocarrierefficientlydelivershighlywatersolubledrugacrossthebloodbrainbarrierintobrain
AT mitachatterjeedebnath lipidbasednanocarrierefficientlydelivershighlywatersolubledrugacrossthebloodbrainbarrierintobrain